Vector Science & Therapeutics Corp. Grants Options as Company Advances Growth Strategy

Executive Summary

• The Board of Directors approved the grant of 206,610 stock options to certain company directors under the company's existing stock option plan.
• The options carry a C$1.69 exercise price, vest throughout the remainder of 2026, and are exercisable for a five-year period from the grant date.
• The grant remains subject to final approval by the TSX Venture Exchange.

Key Details

• Options Granted: 206,610 stock options
• Recipients: Certain directors of Vector Science & Therapeutics Corp.
• Exercise Price: C$1.69 per option
• Vesting Schedule: Throughout the remainder of 2026
• Exercise Term: Five years from the date of grant
• Regulatory Status: Subject to TSX Venture Exchange approval
• Stock Option Plan Structure: 10% rolling plan
• Total Common Shares Reserved Under Plan: 6,556,610 shares
• Options Remaining for Issuance: 8,792,446 options
• Company Ticker: TSXV: PAIN